A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than ...

HealthDay News — Racial and ethnic disparities are seen in the use of obesity-management medications, according to a study published online Dec. 17 in the Journal of Racial and Ethnic Health ...

The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

The 38-year-old information technology worker from New Mexico had a prescription ... Now that millions of people have used the drugs, several obesity experts told The Associated Press that ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and ...

While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials decided to indefinitely pause covering their use for weight loss patients ...

Dr. Bisher Mustafa of the Marshall Health Obesity Clinic in Huntington said there's a certain irony to waiting "until people have diabetes to start the medication.” “The idea is to try to ...